ESR1 and neoplasm: A dose dependent downregulation of ER expression was observed in the harvested tumor tissues when evaluated by immunoblot of the cleared lysates derived from fulvestrant-treated tumors (relative ER levels are presented in Fig. 1d, primary blots are included in Online Resource 1a).